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In heterozygous patients, the amount of some 
human P-chain variants in peripheral blood is much 
lower than that of the normal component A. This is 
mostly the case of unstable hemoglobins, in relation 
with protein destruction [ 1 j. The abnormal compo- 
nent is also diminished in heterozygous patients with 
hemoglobin E, usually ranging from 25 to 35%. 
According to Rieder, this decrease could be explained 
by both a disturbed synthesis and an instability of 
hemoglobin E [2]. 
We had recently the opportunity of studying 
hemoglobin E in various kinds of association (hetero- 
zygous A, E and E-/3” thalassemia) and in homozygous 
E, and demonstrated that the structural abnormality, 
located in a contact area between subunits, gave rise 
to some discrete functional disorders [3]. 
In this work, we describe the synthesis of hemo- 
globin in the same patients. Our data give evidence 
for a decrease synthesis as proposed by Rieder [2]. 
Nevertheless, the specific activity ratios DE/p* meas- 
ured on the heterozygous patient at various times of 
incubation are not consistent with an instability of 
the protein as it was suggested by Rieder [2]. Gel 
filtration experiments bring arguments for the 
presence of a defect in the association of the newly 
synthesized subunits in the homozygous patient. 
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2. Materials and methods 
Blood was collected in heparinized tubes and the 
reticulocyte count was increased by centrifugation. 
The in vitro synthesis of hemoglobin was studied 
according to Borsook [4] with slight modifications, 
using [3 Hlleucine as a marker. The globin was 
prepared by acid acetone and the polypeptide chains 
fractionated [5]. The radioactivity was determined in 
each fraction by liquid scintillation counting of 
aliquots; the total radioactivity incorporated into the 
chains was estimated and the specific activity expres- 
sed as the ratio of counts per min, per ml and per 
optical density unit at 280 nm. After a 60 min 
incubation, a gel filtration was run immediately as 
previously described [6]. 
3. Results and discussion 
3.1. E-/3” thulassemia hemog[bbin studies 
After a 1 hr incubation of the cells from the E$” 
thalassemic patient, the total synthetic ratio fl + y / cx 
chains was equal to 0.46. The percentage of radio- 
activity incorporated into /3E chains was only 20 per 
cent and the total activity ratio /S/al was equal to 
0.28. As usually described in such cases, a high level 
of fetal hemoglobin was found (40%) and the y chain 
incorporation amounted to 12% of the total labelling; 
the total activity ratio r/a was equal to 0.17 (table 1). 
By gel filtration, free (Y chains amounting to 16% 
were found. 
These data are in good agreement with those pub- 
lished by Weatherall et al. [7] and can be compared 
252 North-Holland Publishing Company - Amsterdam 
Volume 45, number 1 FEBS LETTERS September 1974 
Table 1 
Total radioactivity incorporated into the chains 
Patient Incubation time Total radioactivity 
(hr) cpm 
Total synthetic ratio 
Y p* DE (2 
Y P P+7 --- 
Q! CY Q 
E-p” Thalassemia 1 39 065 63 970 223 370 0.17 0.28 0.46 
E/E 1 48 150 54 000 0.90 
E/E 4 240 480 336 510 0.74 
NE 1 11000 3 775 14 120 1.05 
The total synthetic ratio shows an unbalanced synthesis for the E-p thalassemic patient. After a 1 hr 
incubation, the (Y and p chain synthesis is balanced for both heterozygous AE and homozygous E. 
to studies of heterozygous S-/3” thalassemia. In 
these latter cases, the total activity ratio OS/o ranged 
from 0.43 to 0.62 [7-lo], and 31% of the total 
incorporation was found in 0s chains [7]. Our results 
can suggest a defective synthesis of 4E chains. 
3.2. Hemoglobin E studies 
The mechanism of disturbed synthesis was studied 
on cells containing only hemoglobin E. After 60 min 
of incubation, the total activity ratio was equal to 
0.9: this value is in the lower normal limits of a 
balanced synthesis. When the incubation was continued 
for 4 hr, the ratio decreased to 0.74 (table 1). 
Two radioactive peaks were observed after gel 
chromatography on Sephadex G-100 (fig. 1). In the 
major peak, eluted with hemoglobin, the total activity1 
ratio flE/a! was 1.2 (fig. 2A); the minor one, corre- 
sponding to a molecular weight of about 30 000, was 
demonstrated to be pure (Y chains; it contained 12% 
of the total radioactivity (fig. 2B). In normal con- 
trols, the free (Y chains pool, expressed in radioactivity 
is 1 or 2%. Tb.e defect of newly synthesized (Y chains 
observed in the tetrameric fraction corresponds 
exactly to this OL dimers peak. On the other hand, the 
excess of labelled fi chains could be explained by the 
existence of abnormal /.?E4 tetramers, having the same 
electrophoretical mobility as hemoglobin E. 
A large pool of free CY chains has been described 
in /3-thalassemia [7,11] where 0 chain synthesis is 
decreased, and in some unstable hemoglobins [ 1 ,121, 
in relation with an enhanced degradation. The results 
are not completely explained by a decreased synthesis 
since we observed an almost balanced synthesis 
between /_?E and LY chains. 
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Fig. 1. Red blood cell homolysate of an homozygous patient 
E/E Elution pattern on Sephadex G-100. Peak 1 corresponds 
to hemoglobin and peak II to a molecular weight of about 
30 000. 
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Fig. 2. A. Chain separation of peak I: the ratio of total radio- 
activity pE/o is equal to 1.2; B. Chain separation of peak II 
after addition of carrier hemoglobin. Only the OL chains are 
labelled. 
3.3. Hemoglobin AE studies 
In order to investigate the possible instability of 
hemoglobin E, the heterozygous patient’s reticulocytes 
were incubated for various times ranging from 15- 
120 min. The low incorporation made shorter incuba- 
tions impossible. The specific activity ratio was found 
constant and always inferior to 1 (table 2). These 
results differ from what has been described for 
unstable hemoglobins [ 11. Moreover, no abnormal 
heat stability could be demonstrated. 
These data favor a decreased synthesis of hemo- 
globin E. 
To summarize our results, we found obvious 
similarities between the homozygous E/E and the 
doubly heterozygous E-/I0 thalassemic patients, the 
most striking feature being the abnormal large pool 
Table 2 
Study of the specific activity ratio pE/pA 
Incubation time 
Wn) 
Specific activity Specific activity 
cpm/ml/O.D. unit ratio 
- 
BE PA @E/PA 
15 208 260 0.80 
30 380 505 0.75 
60 635 890 0.71 
120 1020 1325 0.77 
Only slight modifications are observed over a period of time 
ranging from 15 to 120 min. This value is always smaller 
than 1, indicating a pE chain defective synthesis. 
of free (Y chains. Some disparities have been noticed 
between the synthetic ratios observed in E-0” thalas- 
semia and S-/3” thalassemia. It is postulated that in 
heterozygous P-thalassemia regulatory mechanism 
exists in the nucleated cells accounting for an apparent 
balanced synthesis of the subunits in the bone 
marrow [8,13]. If we assume a decreased or delayed 
association of (Y and /3E chains, and also a diminished 
synthesis of .@ chains, a similar mechanism could be 
evoked to explain the various results. In the hetero- 
zygous patients, there may be some compensatory 
increase in the production of PA from the normal PA 
gene, together with a reduction of the total globin 
synthesis. In the homozygous patient, the compensa- 
tion is only at the expense of total production of 
hemoglobin; it gives rise to an almost balanced 
synthesis after 1 hr, but would not be more efficient 
after a long incubation. In the double heterozygous 
E-/3” thalassemic patient, the production of y chains 
is relatively high, but insufficient nevertheless to 
compensate for the defect bf both PA and /3E genes. 
This patient is anemic and hypochromic. 
The regulatory effect of free cr chains on its own 
synthesis has been demonstrated [14]. It could be 
involved as a factor in the overall regulation of globin 
chain synthesis. 
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